Why Organon (OGN) Is Up 13.4% After Expanding Nilemdo Rights In Six European Markets
On 8 January 2026, Organon announced an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) across…
Browsing Tag